BioNTech Investor Day Presentation Deck

Scaling up mRNA batch numbers: Marburg BIONTECH Manufacturing and automation Acquired from Novartis in 2020 for less than EUR 100M >100,000 square ft and 8 retrofitted production suites Retrofitted to produce mRNA vaccine within 6 months of acquisition >1.5 billion doses of COVID-19 vaccine produced since Q2 2021 BioN Tainer development hub BIONTECH 51

View entire presentation